Solid Biosciences (SLDB) AGM 2026 summary

Opening remarks and agenda

• Meeting called to order as a virtual-only event, ensuring stockholders have full participation rights and opportunities to ask questions.

• Introductions made for board members, executive team, legal counsel, and Inspector of Election.

Corporate governance

• Notice of annual meeting and proxy statement were sent to all stockholders of record as of April 16, 2026.

• Quorum established with 86.57% of shares represented, allowing business to proceed.

Board and executive committee updates

• Election of three Class II directors (Clare Kahn, Adam Stone, Lynne Sullivan) to serve until the 2029 annual meeting.

• Ratification of Ilan Ganot as a Class I director on an advisory basis until the 2028 annual meeting.